Table 1 Characteristics of the whole cohort
From: Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor
Number of women | % | |
|---|---|---|
Median time of follow-up (years) | 5.4 | |
Interquartile range (years) | 2.5 to 6 | |
Mean age at diagnosis (years ± SD) | 47.77 ± 16.45 | |
Histology (n = 46): | ||
Serous | 21 | 45.7 |
Mucinous (intestinal + Müllerian) | 24 | 52.2 |
Clear-cell tumor | 1 | 2.1 |
CA125 or CA199 before surgery (n = 34): | ||
Elevated (>35 UNL) | 27 | 79.4 |
Normal | 7 | 20.6 |
Approach (n = 46): | ||
Laparotomy | 40 | 87.0 |
Laparoscopy | 6 | 13.0 |
Surgery (n = 46): | ||
Complete | 21 | 45.7 |
Incomplete | 25 | 54.3 |
Lymphadenectomy (n = 46): | ||
Pelvic +/− para-aortic | 21 | 45.7 |
None | 25 | 54.3 |
Intraoperative cyst rupture (n = 44): | ||
Yes | 2 | 4.5 |
No | 42 | 95.5 |
Pathologic cyst rupture (n = 46): | ||
Yes | 10 | 21.7 |
No | 36 | 78.3 |
Peritoneal implants (n = 46): | ||
Invasive | 0 | 0.0 |
Non-invasive | 2 | 4.3 |
None | 33 | 71.7 |
Not described by surgeon | 11 | 23.9 |
Peritoneal washings (n = 46): | ||
Positive | 0 | 0.0 |
Negative | 46 | 100.0 |
FIGO staging (n = 46): | ||
IA | 23 | 50.0 |
IB | 7 | 15.2 |
IC | 12 | 26.1 |
≥II | 3 | 6.5 |
Information not available | 1 | 2.2 |